Fed must cut rates more aggressively due to jobs: Canaccord Tony Dwyer

The Federal Reserve may have new incentives in the second quarter to cut rates deeper this year. Canaccord Genuity’s Tony Dwyer thinks a deteriorating jobs market and easing inflation will ultimately push the Fed to act. “I’m not saying that they have to go back to zero, but they have to be more aggressive,” the … Read more

Falling fertility rates pose major challenges for the global economy

Terry Vine | Getty Images Falling fertility rates are set to spark a transformational demographic shift over the next 25 years, with major implications for the global economy, according to a new study. By 2050, three-quarters of countries are forecast to fall below the population replacement birth rate of 2.1 babies per female, research published … Read more

Ambient clinical documentation steals the show

Attendees at HIMSS in Orlando, Florida 2024. Courtesy of HIMSS The hottest new technology for doctors promises to bring back an age-old health-care practice: face-to-face conversations with patients. As more than 30,000 health and tech professionals gathered among the palm trees at the HIMSS conference in Orlando, Florida, this week, ambient clinical documentation was the … Read more

An overlooked corner of women’s health may be $350 billion market opportunity

Peathegee Inc | Tetra Images | Getty Images After years of being ignored, menopause has entered the public conversation. Celebrities from Drew Barrymore to Naomi Watts have opened up about symptoms and promoted products. Yet despite the increased chatter, there is a long way to go when it comes to treating symptoms — and a … Read more

Biden administration investigating Change Healthcare cyberattack

In this photo illustration, the UnitedHealth Group logo is displayed on a tablet. Igor Golovniov | Sopa Images | Lightrocket | Getty Images The U.S. Department of Health and Human Services has launched an investigation into UnitedHealth Group following the cyberattack on its Change Healthcare unit that has disrupted crucial operations in pharmacies and hospitals … Read more

Pfizer is betting big on cancer drugs after Covid decline

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off.  Pfizer pitched its … Read more

GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday. Earlier this month, Goldman Sachs … Read more

Nvidia rally fueling FOMO in overall market: Evercore’s Julian Emanuel

Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and subsequent collapse, are more worried about being underinvested than overexposed right now. “That’s the first time that’s happened since 2021 for us,” the firm’s senior … Read more

Foreign aid drops sharply as Taliban abuses jeopardize the Afghan health system, group says

ISLAMABAD — Human Rights Watch said Monday that Afghanistan’s public health system has been hit hard following a sharp reduction in foreign assistance, coupled with serious Taliban abuses against women and girls, jeopardizing the right to healthcare of millions of Afghans. In a new report, the New York-based watchdog said this has left the “Afghan … Read more

Eli Lilly (LLY) earnings Q4 2023

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.  Brendan McDermid | Reuters Eli Lilly on Tuesday reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, … Read more